-
-
-
-
-
-
-
Ernexa Therapeutics reports complete tumor elimination in ovarian cancer study
-
-
-
-
-
-
-
Cellipont partners with Ernexa to manufacture ERNA-101 cancer therapy
-
-
-
-
-
-
-
Ernexa Therapeutics (ERNA) Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025
-
-
-
-
-
-
-
Eterna Therapeutics (ERNA) Files for 49.87M Share Offering by Selling Stockholders
-
448,041 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

